Sign in
4

Changes in Ownership

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Filed Acc 0001127602-25-020282

EVP, Corp Strategy & Develop sold 400 shares at $150.04 ($60,016)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
LaPlume Joseph W EVP, Corp Strategy & Develop 2025-08-07 Sale −400 $150.04 $60,016 24,916 D
Open-market sales · 400 sh · avg $150.04 · $60,016
Loading xslF345X05/form4.xml…